Roche's Phase III Hemlibra Data Reinforce Safety Profile In People With Haemophilia A

Roche (RHHBY) said that final analysis from phase IIIb STASEY study, including data from 193 people with haemophilia A, further supported the benefit/risk profile of Hemlibra or emicizumab. The study results consistent with the phase III HAVEN clinical program.

In the analysis, no new safety signals were identified with longer-term Hemlibra treatment in adults and adolescents with haemophilia A with inhibitors to factor VIII, the clotting protein that is missing or defective in people with haemophilia A.

The data were presented at the virtual International Society on Thrombosis and Haemostasis 2021 Congress, 17-21 July 2021.

The analysis did not show any new cases of thrombotic microangiopathy or serious thrombotic events related to Hemlibra. The most common adverse events occurring in 10% or more of people in the STASEY study were joint pain, common cold symptoms , headache, injection site reaction and fever.

The company noted that Hemlibra also continued to demonstrate effective bleed control in the STASEY study, with 82.6% of participants experiencing no bleeding episodes that required treatment. Annualised bleeding rates were consistent with previously reported observations from the pivotal HAVEN studies.

Hemlibra has been approved in more than 100 countries worldwide for the treatment of people with haemophilia A with factor VIII inhibitors.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Velvet Ice Cream recalled certain lots of its 56 oz Raspberry Fudge Cordial Ice Cream for potentially containing undeclared peanuts, the U.S. Food and Drug Administration or FDA said in a statement. The recall was initiated after it was notified of the issue by a single customer and has since learned that the cause of the error has been traced to a third-party manufacturer packaging error. Willard, Ohio-based Buurma Farms Inc. is recalling 320 boxes of its Plain Parsley citing possible contamination with Shiga-toxin producing E.coli, the U.S. Food and Drug Administration said. The recall involves Buurma Plain (flat leaf) Parsley with a harvest date of August 30, 2021 from their Gregory, Michigan location. Molson Coors Beverage Co. is bringing Topo Chico Hard Seltzer, the sparkling mineral water, across the United States starting January 2022. The company will officially expand the distribution of the product, which was launched last spring in nine states and seven metro areas, to all 50 states. Molson Coors is manufacturing, marketing and distributing Topo Chico Hard Seltzer in the U.S.
Follow RTT